Noninvasive Markers of Functional Nausea in Children
Public ClinicalTrials.gov record NCT03593811. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The researchers propose to study how functional nausea in adolescents may be characterized noninvasively by the use of multichannel electrogastrogram (EGG) and magnetogastrogram (MGG) recordings.
Study identification
- NCT ID
- NCT03593811
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Early Phase 1
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Questionnaires Diagnostic Test
- 4 channel electrogastrogram (EGG) Diagnostic Test
- 36 channel high resolution electrogastrogram (HR-EGG) Diagnostic Test
- Magnetogastrogram (MGG) Diagnostic Test
- Electrocardiogram (EKG) Diagnostic Test
- Ondansetron Drug
- Cyproheptadine Oral Tablet Drug
Diagnostic Test · Drug
Eligibility (public fields only)
- Age range
- 8 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2, 2018
- Primary completion
- Apr 1, 2021
- Completion
- Apr 1, 2021
- Last update posted
- Apr 21, 2026
2018 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Nausea trials
Other public records listing Nausea. Sorted by last update posted; newest first. Not a recommendation.
- NCT06740812: Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide Not yet recruiting
- NCT06382012: Antiemetic Fosaprepitant To Remedy Nausea and Vomiting Recruiting
- NCT06464926: Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE) Recruiting
- NCT07169851: A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer Recruiting
- NCT07378839: Alternate Nostril Breathing (ANB) for 1st Trimester Nausea and Vomiting Recruiting
- NCT05418244: Inhaled Isopropyl Alcohol for Treatment of Nausea Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03593811, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03593811 live on ClinicalTrials.gov.